Ericsson, C D <br/><br/>
Role of a novel antidiarrheal agent, BW942C, alone or in combination with trimethoprim-sulfamethoxazole in the treatment of traveler's diarrhea.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jun 1986 
 - 1040-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.29.6.1040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidiarrheals--adverse effects<br/>Clinical Trials as Topic<br/>Diarrhea--drug therapy<br/>Double-Blind Method<br/>Drug Combinations--adverse effects<br/>Enkephalin, Methionine--adverse effects<br/>Enkephalins<br/>Feces--microbiology<br/>Female<br/>Humans<br/>Male<br/>Mexico<br/>Random Allocation<br/>Sulfamethoxazole--adverse effects<br/>Travel<br/>Trimethoprim--adverse effects<br/>Trimethoprim, Sulfamethoxazole Drug Combination<br/>United States